Shenzhen Zhongjia Biomedical Technology Co., Ltd. Shenzhen Zhongjia Biomedical Technology Co., Ltd.

Products Center

Products Center

Home > Products Center
Products Center

DC-CIK Kit

  • Product features: The system is highly stable. The DC-CIK kit developed by our company adopts a cytokine-only, serum-free culture method with defined components and high batch stability. All selected raw materials are medical-grade drugs and can be directly infused into the human body.

    Culture features: High DC maturity; DC cells are rapidly activated within 24 h, with stronger DC activation and stronger expression of costimulatory molecules; high surface phenotype with CD80+>80%, CD86+>80%, CD83+>60% and HLA-DR>80%; broad action against various tumor-specific and broad-spectrum antigens, multiple immunosuppressive factors, chemo- and radiotherapy-resistant tumor stem cells, and matrix metalloproteinases that promote tumor cell spread. All selected raw materials and reagents are medical-grade with no potential risks.